El Bachir Kaloun,Karim Bedjeguelal,Rémi Rabot,Anna Kruczynski,Philippe Schmitt,Michel Perez,Nicolas Rahier
申请号：
US13686334
公开号：
US08883821B2
申请日:
2012.11.27
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to a compound of following formula (I):or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimers disease to the use of same as a kinase inhibitor to the pharmaceutical compositions comprising same and to methods for the preparation of same.
